SCHEMBL2820609

SCHEMBL2820609

CN(C)c1ncc(CN2CCC3(CC2)CCN(C(=O)c2ccc4c(c2)C(NC(=O)c2c(F)cccc2Cl)CC4)C3)cn1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 9/20 0.39
CYP3A4 P08684 7/20 0.39
CYP2C9 P11712 4/20 0.39
CYP1A2 P05177 4/20 0.39
CYP2C19 P33261 2/20 0.39
MAPK1 P28482 2/20 0.38
USP2 O75604 5/20 0.38
RECQL P46063 1/20 0.38
HPGD P15428 3/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 2/20 0.36
MAPK7 Q13164 1/20 0.36
BDKRB1 P46663 4/20 0.36
ACKR3 P25106 1/20 0.36
EPHX2 P34913 1/20 0.35
PRKAA2 P54646 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA1A P35348 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2818585 0.93 BDKRB1 (0.38) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL485266 0.90 P2RX7 (0.39) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL484564 0.89 TAS1R3 (0.38) CYP2D6CYP3A4CYP2C19MAPK1ALDH1A1
SCHEMBL484843 0.87 CYP2D6 (0.41) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL484363 0.85 CYP3A4 (0.53) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL485164 0.85 P2RX7 (0.40) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL484545 0.85 CCR3 (0.42) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL2818735 0.85 CRHR1 (0.40) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL484966 0.84 ALPI (0.39) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19
SCHEMBL484330 0.84 CYP2D6 (0.49) CYP2D6CYP3A4CYP2C9CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885CYP2C9 2259/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN CYP2D6 1926/4885CYP3A4 3781/4885CYP2C9 2259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.